Sight Sciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
/ 
Frequently asked questions
To buy Sight Sciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sight Sciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sight Sciences Inc. is SGHT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sight Sciences Inc. has its primary listing on NASDAQ. You can trade Sight Sciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sight Sciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Sight Sciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Sight Sciences Inc..